Necessity for re-vascularization after spinal cord injury and the search for potential therapeutic options

Current Neurovascular Research

Volumn 8, Issue 4, 2011, Pages 334-341

  Graumann, Ursula ^a   Ritz, Marie Françoise ^b   Hausmann, Oliver ^c  

^a SWISS PARAPLEGIC RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Klinik St Anna   (Switzerland)

Author keywords

Angiogenesis; Angiogenic factors; Blood vessels; Cell based therapy; Re vascularization; Spinal cord injury

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN A;

ARTICLE; BLEEDING; BLOOD BRAIN BARRIER; BLOOD COMPONENT; CELL DEATH; EDEMA; HUMAN; INFLAMMATION; NERVE CELL; PRIORITY JOURNAL; REVASCULARIZATION; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA;

EID: 82155191629     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/156720211798121007     Document Type: Article

References (77)

1. Tator CH, Koyanagi I. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg. 1997; 86(3):483-92. (Pubitemid 27097095)
2. Sharma HS. Pathophysiology of blood-spinal cord barrier in traumatic injury and repair. Curr Pharm Des. 2005; 11(11):1353-89. (Pubitemid 40598002)
3. Imperato-Kalmar EL, Mc Kinney RA, Schnell L, et al. Local changes in vascular architecture following partial spinal cord lesion in the rat Exp Neurol. 1997; 145(2 Pt 1):322-8. (Pubitemid 27314784)
4. Casella GT, Marcillo A, Bunge MB, et al. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol. 2002; 173(1):63-76. (Pubitemid 34081726)
5. Loy DN, Crawford CH, Darnall JB, et al. Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat J Comp Neurol. 2002; 445(4):308-24. (Pubitemid 34252854)
6. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003; 314(1):15-23. (Pubitemid 37409909)
7. Popovich PG, Horner PJ, Mullin BB, et al. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol. 1996; 142(2):258-75. (Pubitemid 26414059)
8. Maikos JT, Shreiber DI. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J Neurotrauma. 2007; 24(3):492-507. (Pubitemid 46598283)
9. Hausmann ON. Post-traumatic inflammation following spinal cord injury. Spinal Cord. 2003; 41(7):369-78. (Pubitemid 36819586)
10. Pan W, Kastin AJ. Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol. 2001; 170(2):357-63. (Pubitemid 32758688)
11. Rieckmann P, Engelhardt B. Building up the blood-brain barrier. Nat Med. 2003; 9(7):828-9. (Pubitemid 36889920)
12. Whetstone WD, Hsu JY, Eisenberg M, et al. Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J Neurosci Res. 2003; 74(2):227-39. (Pubitemid 37193709)
13. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc. 2000; 5(1):40-6. (Pubitemid 32044088)
14. Buckley-Sturrock A, Woodward SC, Senior RM, et al. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol. 1989; 138(1):70-8. (Pubitemid 19038673)
15. Schreier T, Degen E, Baschong W. Fibroblast migration and proliferation during in vitro wound healing. A quantitative comparison between various growth factors and a low molecular weight blood dialysate used in the clinic to normalize impaired wound healing. Res Exp Med (Berl). 1993; 193(4):195-205. (Pubitemid 23253255)
16. Kanazawa S, Fujiwara T, Matsuzaki S, et al. b FGF regulates PI3- kinase-Rac 1-JNK pathway and promotes fibroblast migration in wound healing. PLoS One. 2010; 5(8):e12228.
17. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23(5):1011-27. (Pubitemid 46202320)
18. Bartholdi D, Rubin BP, Schwab ME. VEGF m RNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat Eur J Neurosci. 1997; 9(12):2549-60. (Pubitemid 28082944)
19. Ritz MF, Graumann U, Gutierrez B, et al. Traumatic Spinal Cord Injury Alters Angiogenic Factors and TGF-Beta1 that may Affect Vascular Recovery. Curr Neurovasc Res. 2010; 7(4):301-10.
20. Herrera JJ, Nesic O, Narayana PA. Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J Neurotrauma. 2009; 26(7):995-1003.
21. Choi JS, Kim HY, Cha JH, et al. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem. 2007; 55(8):821-30.
22. Autiero M, Waltenberger J, Communi D, et al. Role of Pl GF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003; 9(7):936-43. (Pubitemid 36889938)
23. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000; 6(4):389-95. (Pubitemid 30208155)
24. Liu H, Honmou O, Harada K, et al. Neuroprotection by Pl GF gene- modified human mesenchymal stem cells after cerebral ischaemia. Brain. 2006; 129(Pt 10):2734-45. (Pubitemid 44522106)
25. Hori S, Ohtsuki S, Hosoya K, et al. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem. 2004; 89(2):503-13. (Pubitemid 38495998)
26. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000; 6(4):460-3. (Pubitemid 30208166)
27. Beck H, Acker T, Wiessner C, et al. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat Am J Pathol. 2000; 157(5):1473-83.
28. Lindahl P, Johansson BR, Leveen P, et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997; 277(5323):242-5. (Pubitemid 27446080)
29. Hirschi KK, Rohovsky SA, Beck LH, et al. Endothelial cells modulate the proliferation of mural cell precursors via platelet- derived growth factor-BB and heterotypic cell contact. Circ Res. 1999; 84(3):298-305. (Pubitemid 29095570)
30. Xiyang YB, Liu S, Liu J, et al. Roles of platelet-derived growth factor-B expression in the ventral horn and motor cortex in the spinal cord-hemisected rhesus monkey. J Neurotrauma. 2009; 26(2):275-87.
31. Graumann U, Ritz MF, Rivero BG, et al. CD133 expressing pericytes and relationship to SDF-1 and CXCR4 in spinal cord injury. Curr Neurovasc Res. 2010; 7(2):144-54.
32. Liu Y, Wilkinson FL, Kirton JP, et al. Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol. 2007; 212(1):12-9. (Pubitemid 46746285)
33. Shimamura M, Sato N, Sata M, et al. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Brain Res. 2007; 1151(188-94. (Pubitemid 46709865)
34. Ramsauer M, D'Amore PA. Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J Cell Sci. 2007; 120(Pt 10):1810-7. (Pubitemid 46930419)
35. Nakagawa T, Li JH, Garcia G, et al. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int. 2004; 66(2):605-13. (Pubitemid 38982002)
36. Bobik A. Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006; 26(8):1712-20. (Pubitemid 44305323)
37. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998; 141(3):805-14. (Pubitemid 28217923)
38. Buss A, Pech K, Kakulas BA, et al. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord. 2008; 46(5):364-71. (Pubitemid 351630959)
39. Li XL, Liu J, Wang XY, et al. Temporal changes in the expression of TGF-beta 1 and EGF in the ventral horn of the spinal cord and associated precentral gyrus in adult Rhesus monkeys subjected to cord hemisection. J Neurol Sci. 2008; 268(1-2):163-71.
40. Lagord C, Berry M, Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci. 2002; 20(1):69-92. (Pubitemid 34634329)
41. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol. 2009; 41(4):771-83.
42. Liu H, Yang R, Tinner B, et al. Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology. 2008; 149(4):1666-77. (Pubitemid 351468326)
43. Skovseth DK, Veuger MJ, Sorensen DR et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood. 2005; 105(3):1044-51. (Pubitemid 40170874)
44. Javaherian K, Park SY, Pickl WF, et al. Laminin modulates morphogenic properties of the collagen XVIII endostatin domain. J Biol Chem. 2002; 277(47):45211-8. (Pubitemid 36159125)
45. Yuan S, Fu Y, Wang X, et al. Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB J. 2008; 22(8):2809-20.
46. Mueller CA, Schluesener HJ, Fauser U, et al. Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI). Exp Neurol. 2007; 208(2):228-37. (Pubitemid 350101500)
47. Mueller CA, Schluesener HJ, Conrad S, et al. Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II. J Neurotrauma. 2003; 20(10):1007-15. (Pubitemid 37288560)
48. Park SG, Kang YS, Ahn YH, et al. Dose-dependent biphasic activity of t RNA synthetase-associating factor, p43, in angiogenesis. J Biol Chem. 2002; 277(47): 45243-8. (Pubitemid 36159129)
49. Chang SY, Park SG, Kim S, et al. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation. J Biol Chem. 2002; 277(10):8388-94. (Pubitemid 34968299)
50. Zorner B, Schwab ME. Anti-Nogo on the go: from animal models to a clinical trial. Ann N Y Acad Sci. 2010; 1198(Suppl 1):E22-34.
51. Ronaghi M, Erceg S, Moreno-Manzano V, et al. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells. 2010; 28(1):93-9.
52. Widenfalk J, Lipson A, Jubran M, et al. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience. 2003; 120(4):951-60. (Pubitemid 36966647)
53. Liu Y, Figley S, Spratt SK, et al. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol Dis. 2010; 37(2):384-93.
54. Patel CB, Cohen DM, Ahobila-Vajjula P, et al. Effect of VEGF treatment on the blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J Neurotrauma. 2009; 26(7):1005-16.
55. Benton RL, Whittemore SR. VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem Res. 2003; 28(11):1693-703. (Pubitemid 37296211)
56. Han S, Arnold SA, Sithu SD, et al. Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury. Brain. 2010; 133(Pt 4):1026-42.
57. Herrera JJ, Sundberg LM, Zentilin L, et al. Sustained Expression of Vascular Endothelial Growth Factor and Angiopoietin-1 Improves Blood-Spinal Cord Barrier Integrity and Functional Recovery after Spinal Cord Injury. J Neurotrauma. 2010; 27(11):2067-76.
58. Kitamura K, Iwanami A, Nakamura M, et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res. 2007; 85(11):2332-42. (Pubitemid 47204748)
59. Kang CE, Clarkson R, Tator CH, et al. Spinal cord blood flow and blood vessel permeabilitymeasured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factor. J Neurotrauma. 2010; 27(11):2041-53.
60. Frontczak-Baniewicz M, Gordon-Krajcer W, Walski M. The immature endothelial cell in new vessel formation following surgical injury in rat brain. Neuro Endocrinol Lett. 2006; 27(4):539-46. (Pubitemid 46043615)
61. Morgan R, Kreipke CW, Roberts G, et al. Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis. Neurol Res. 2007; 29(4):375-81. (Pubitemid 47196056)
62. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. (Pubitemid 27087709)
63. Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999; 18(14):3964-72. (Pubitemid 29335849)
64. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. (Pubitemid 39070860)
65. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999; 5(4):434-8. (Pubitemid 29180584)
66. George J, Goldstein E, Abashidze A, et al. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. Cardiovasc Res. 2005; 68(2):299-306. (Pubitemid 41428426)
67. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 2003; 108(4):457-63. (Pubitemid 36935540)
68. Finney MR, Fanning LR, Joseph ME, et al. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy. 2010; 12(1):67-78.
69. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001; 103(23):2776-9. (Pubitemid 32550062)
70. Mund JA, Ingram DA, Yoder MC, et al. Endothelial progenitor cells and cardiovascular cell-based therapies. Cytotherapy. 2009; 11(2):103-13.
71. Geffner LF, Santacruz P, Izurieta M, et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant. 2008; 17(12):1277-93.
72. Sasaki H, Ishikawa M, Tanaka N, et al. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine (Phila Pa 1976). 2009; 34(3):249-54.
73. Cai X, Lin Y, Friedrich CC, et al. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev. 2009; 5(4):437-45.
74. Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004; 22(3):377-84. (Pubitemid 38736621)
75. Zeng X, Zeng Y-S, Ma Y-H, et al. Angiogenesis and Reduce Cavity Formation in Experimental Spinal Cord Injury. Cell Tansplantation. 2011; in press.
76. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004; 8(4):498-508. (Pubitemid 44145482)
77. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003; 9(6):702-12. (Pubitemid 36749219)